The histone deacetylase inhibitor belinostat ameliorates experimental autoimmune encephalomyelitis in mice by inhibiting TLR2/MyD88 and HDAC3/ NF-κB p65-mediated neuroinflammation
Yanjia Shen(Chinese Academy of Medical Sciences & Peking Union Medical College), Guanhua Du(Shanghai Jiao Tong University), Hou‐Zao Chen(Chinese Academy of Medical Sciences & Peking Union Medical College), De‐Pei Liu(Chinese Academy of Medical Sciences & Peking Union Medical College), Li Li(Army Medical University), Miao Chen(Chinese Academy of Medical Sciences & Peking Union Medical College), Jiaying Zhao(Chinese Academy of Medical Sciences & Peking Union Medical College), Shuhan Chen(Southwest Medical University), Ran Yang(Chinese Academy of Medical Sciences & Peking Union Medical College), Baixi Ji(Chinese Academy of Medical Sciences & Peking Union Medical College)
Cited by 57
Related Papers
Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial
|The Lancet|2020|3.7k
A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus–induced lung injury
|Nature Medicine|2005|3.7k
Cancer incidence and mortality in China, 2016
|Journal of the National Cancer Center|2022|1.6k
Loss of Cardiac Ferritin H Facilitates Cardiomyopathy via Slc7a11-Mediated Ferroptosis
|Circulation Research|2020|767
Endothelium-specific overexpression of class III deacetylase SIRT1 decreases atherosclerosis in apolipoprotein E-deficient mice
|Cardiovascular Research|2008|388